Guidelines

A company whose prescription opioid marketing practices are being blamed for sparking the addiction and overdose crisis says it’s helping to fund an effort to make a lower-cost overdose antidote.

Last year, the college of physicians and surgeons of Saskatchewan received 2,905 calls from concerned patients—a record high, up nearly 500 from the 2,408 they received in 2016.

Provinces must often make ad hoc decisions about which expensive drugs for rare diseases to cover, but some researchers argue that needs to change

Six new cases reported during the week of August 26 to September 1

Also suggest offering Shingrix to those 50 years or older previously vaccinated with Zostavax

The ongoing NAFTA renegotiations could put a Canadian national pharmacare program in jeopardy, and could have a particular impact on Canadians who need expensive arthritis drugs